Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurexan in experimental acute stress
NCT01703819Phase 2Completed
- Sponsor
- Heel
- Start
- Oct 2012
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute stress reaction (ASR) comparing Neurexan with Placebo (2 arms). Primary endpoints: Acute Stress Measured by Tension and Acute Stress Measured by Nervousness. Started Oct 2012; status: completed.
02
Drugs
Neurexan
03
Conditions
acute stress reaction (ASR)
Beyond the preview
Go deeper on NCT01703819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01703819.